Preface

There are still many unmet medical requirements, including brain tumours. Brain tumours can now be treated with considerably less toxicity and better pharmacokinetics and pharmacodynamics because of recent nano-drug delivery technologies. It is still difficult to treat brain tumours due to their rapid growth and poor prognoses, even with surgery, radiation, and chemotherapies. To combat the disease, therapeutic delivery methods that maximise drug accumulation in the tumour location and decrease toxicity in normal brain and peripheral tissue are a potential new strategy. The fact that brain tumours differ in many ways from tumours in other tissues means that drug delivery to brain tumours can take advantage of the constantly changing vascular characteristics and microenvironment. For brain tumour theranostics, nanocarrier-based delivery methods address brain architecture and tumours in addition to the advances and problems in delivering medicines across the blood brain barrier. Theranostics combines diagnostics and therapeutics. A growing number of people are becoming interested in individualised therapy and diagnostics approaches. As well as conserving money, this method also limits the negative effects of a specific goal.

This book contains several sections on nanotechnology, including the most recent developments in the field and practical advice on how to build more effective nanocarriers for medication and gene delivery. There is much helpful information in this book that will help readers to create innovative drug delivery systems for brain tumour therapy that will help to boost nanomedical technology. The key features highlighted in this book are various theranostic-based delivery systems for brain tumour diagnosis and treatment. This book will be of interest to many academicians, scientists, and researchers. It will enable them to understand the possible prospects of nanotechnology for delivering nanocarriers that can better diagnose and cure brain tumours in the future.